Ensuring high quality PA education programmes

Simplifying molecular subtypes of metastatic gastric cancer

Quality of life results from pembrolizumab vs chemotherapy in gastric or gastroesophageal junction cancer

Highlights from ESMO 2019

SPICE: Analysis of enadenotucirev plus nivolumab in metastatic colorectal cancer patients during the dose escalation phase

Nivolumab alone versus nivolumab plus ipilimumab in patients with resectable HCC

Pembrolizumab plus platinum-based chemotherapy for metastatic NSCLC

IMPALA results: Lefitolimod vs standard of care in metastatic colorectal cancer

Blood first assay screening in patients with ALK positive NSCLC

Phase III study of veliparib with carboplatin and paclitaxel in HER2-negative advanced/metastatic gBRCA-associated breast cancer

CUPISCO: Identifying carcinoma of unknown primary patients according to ESMO guidelines

CheckMate 459: Safety and efficacy of nivolumab versus sorafenib as a first-line treatment in advanced hepatocellular carcinoma